吉西他滨
肝内胆管癌
医学
化疗
外科肿瘤学
内科学
顺铂
肝病学
病态的
肿瘤科
胃肠病学
作者
Tatsuaki Sumiyoshi,Kenichiro Uemura,Ryuta Shintakuya,Kenjiro Okada,Hiroyuki Otsuka,Masahiro Serikawa,Yasutaka Ishii,Taijū Tsuboi,Koji Arihiro,Shinya Takahashi
标识
DOI:10.1007/s12328-022-01700-x
摘要
The standard chemotherapy for patients with unresectable cholangiocarcinoma is gemcitabine plus cisplatin, and gemcitabine plus S-1 (GS) chemotherapy is also reported to have similar effectiveness in Japan. However, the response rates of these two chemotherapies were modest, and no patients with intrahepatic cholangiocarcinoma (ICC) have shown a pathological complete response (pCR) following these chemotherapies. We report here the first case of an initially unresectable locally advanced ICC that achieved pCR following GS chemotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI